Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:31 PM EST

Emergent BioSolutions (EBS) Net Short-Term Debt Issued (Repaid) (2019 - 2024)

Updated

Analysis

Emergent BioSolutions (EBS) Net Short-Term Debt Issued (Repaid) (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -4.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -24.00 Mn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -222.70 Mn
Jun 30, 2024 -56.50 Mn
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 -12.00 Mn
Sep 30, 2023 -39.00 Mn
Jun 30, 2023 -347.80 Mn
Sep 30, 2020 -353.00 Mn
Mar 31, 2020 -20.00 Mn
Dec 31, 2019 -10.00 Mn
Sep 30, 2019 -15.00 Mn
Jun 30, 2019 100.00 Mn
Mar 31, 2019 -50.00 Mn
API Access

Emergent BioSolutions Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY